Medtronic Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023	Apr '22 Apr 29, 2022
Revenue	36,364	33,537	32,364	31,227	31,686
Revenue Growth (YoY)	8.43%	3.62%	3.64%	-1.45%	5.21%
Cost of Revenue	12,721	11,632	11,216	10,719	10,145
Gross Profit	23,643	21,905	21,148	20,508	21,541
Selling, General & Admin	11,784	10,849	10,736	10,415	10,292
Depreciation & Amortization Expenses	1,772	1,807	1,693	1,698	1,733
Research & Development	2,873	2,732	2,735	2,696	2,746
Other Operating Expenses	748	561	839	214	1,017
Total Operating Expenses	17,177	15,949	16,003	15,023	15,788
Operating Income	6,467	5,955	5,144	5,485	5,752
Interest Expense	-715	-729	-719	-636	-553
Other Non-Operating Income (Expense)	384	402	412	515	318
Total Non-Operating Income (Expense)	-331	-327	-307	-121	-235
Pretax Income	6,136	5,628	4,837	5,364	5,517
Provision for Income Taxes	1,299	936	1,133	1,580	456
Net Income	4,837	4,691	3,705	3,784	5,062
Minority Interest in Earnings	37	29	28	26	22
Net Income to Common	4,801	4,662	3,676	3,758	5,039
Net Income Growth	2.98%	26.82%	-2.18%	-25.42%	39.74%
Shares Outstanding (Basic)	1,282	1,286	1,328	1,330	1,342
Shares Outstanding (Diluted)	1,288	1,290	1,330	1,333	1,351
Shares Change (YoY)	-0.14%	-3.03%	-0.19%	-1.38%	-0.19%
EPS (Basic)	3.75	3.63	2.77	2.83	3.75
EPS (Diluted)	3.73	3.61	2.76	2.82	3.73
EPS Growth	3.32%	30.80%	-2.13%	-24.40%	40.23%
Free Cash Flow	5,426	5,185	5,200	4,580	5,978
Free Cash Flow Growth	4.65%	-0.29%	13.54%	-23.39%	22.38%
Free Cash Flow Per Share	4.21	4.02	3.91	3.44	4.42
Dividends Per Share	2.840	2.800	2.760	2.720	2.520
Dividend Growth	1.43%	1.45%	1.47%	7.94%	8.62%
Gross Margin	65.02%	65.32%	65.34%	65.67%	67.98%
Operating Margin	17.78%	17.76%	15.89%	17.56%	18.15%
Profit Margin	13.30%	13.99%	11.45%	12.12%	15.98%
FCF Margin	14.92%	15.46%	16.07%	14.67%	18.87%
EBITDA	9,425	8,816	7,791	8,182	8,459
EBITDA Margin	25.92%	26.29%	24.07%	26.20%	26.70%
EBIT	6,467	5,955	5,144	5,485	5,752
EBIT Margin	17.78%	17.76%	15.89%	17.56%	18.15%
Effective Tax Rate	21.17%	16.63%	23.42%	29.46%	8.27%

SEC Filings: 10-K · 10-Q